ADAGIO MEDICAL HOLDINGS, INC. Business Acquisition, Pro Forma Revenue
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Business Acquisition, Pro Forma Revenue of $465 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-03-27
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2024-12-31 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2024-09-30 was $185.00, a 351.22% increase year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $41.00.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2024 was $465.00, a 109.46% increase from fiscal 2023.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2023 was $222.00.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $185.00 derived: sum of 2 quarters · filed 2025-03-27 | $465.00 10-K · filed 2025-03-27 | |
| 2024-09-30 | $185.00 10-Q · filed 2024-11-14 | $465.00 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $41.00 derived: sum of 2 quarters · filed 2025-03-27 | $222.00 10-K · filed 2025-03-27 | |
| 2023-09-30 | $41.00 10-Q · filed 2024-11-14 | $222.00 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |